Clinical Trials Directory

Trials / Unknown

UnknownNCT02627755

GlideScope® vs GlideScope® + aScope® for Managing Difficult Airways.

GlideScope® vs GlideScope® + aScope® for Managing Difficult Airways. Assessment of a New Procedure for Endotracheal Intubation in Patients With Suspected Difficult Airways

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
160 (estimated)
Sponsor
Hospital de Manises · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The use in a combined way of two systems of intubation (Glidescope + aScope) would condition an increase in the success rate of endotracheal intubation maneuver compared to conventional isolated Glidescope use in patients with clinical criteria of difficult airway.

Detailed description

Worldwide, up to 600 patients are estimated to die annually as a result of the complications that occur during tracheal intubation The GlideScope® (videolaryngoscope) is used for endotracheal intubation in patients with difficult airway predictors, in this patients overall success intubation rate is 96%. but success intubation rate at first attempt is only 86%. Despite this positive rates, due to high comorbidity when intubation fails, both failure rates (inverse of success rate) are impermissible. 14% failure at the first attempt intubation as well as 4% overall intubation failure. in this study the investigators try to show that new procedure associating aScope® (disposable fiberscope) together with GlideScope® increases the success intubation rate of both ( overall and first attempt).

Conditions

Interventions

TypeNameDescription
DEVICEaScope®we use the aScope® as a flexible and dirigible guide to facilitate the passage of the endotracheal tube through the vocal cords.
DEVICEGlidescope®use of Glidescope® in conventional manner to facilitate endotracheal intubation

Timeline

Start date
2016-11-21
Primary completion
2017-10-01
Completion
2017-11-21
First posted
2015-12-11
Last updated
2017-02-23

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT02627755. Inclusion in this directory is not an endorsement.